Cpt1bm-/- mice have improved glucose disposal regardless of the amount of dietary fat, indicating that pharmacological inhibition of CPT1b may be an effective means of treating metabolic disorders hallmarked by insulin resistance and obesity. This evidence concerns the gene CPT1B and obesity due to melanocortin 4 receptor deficiency.